Categories | Unadjusted | Multivariate | ||||
OR | CI | P-Value | OR | CI | P-Value | |
Age in years | 0.999 | 0.982 - 1.016 | 0.8954 |
|
|
|
Disease Duration | 1.140 | 1.099 - 1.183 | <0.0001** | 0.934 | 0.813 - 1.073 | 0.3353 |
Diagnosis Duration | 1.149 | 1.106 - 1.193 | <0.0001** | 1.241 | 1.074 - 1.434 | 0.0035** |
Gender | 1.126 | 0.774 - 1.637 | 0.5360 |
|
|
|
Race | 1.151 | 0.677 - 1.958 | 0.6028 |
|
|
|
Education |
| |||||
College | 1.189 | 0.733 - 1.927 | 0.4837 |
|
|
|
Graduate | 1.053 | 0.623 - 1.781 | 0.8467 |
|
|
|
Medication Groups |
| |||||
Carbidopa-Levodopa | 1.071 | 0.721 - 1.591 | 0.7328 | 1.571 | 0.830 - 2.971 | 0.1650 |
COMT Inhibitors | 1.041 | 0.638 - 1.699 | 0.8728 |
|
|
|
Dopamine Agonists | 1.010 | 0.684 - 1.492 | 0.9583 |
|
|
|
MAO Inhibitors | 1.753 | 1.055 - 1.910 | 0.0301** | 1.571 | 0.830 - 2.971 | 0.1650 |
Total Number of Medications | 1.002 | 0.887 - 1.133 | 0.9738 |
|
|
|
Total Number of Medication Groups | 1.083 | 0.918 - 1.277 | 0.3449 |
|
|
|